Philippe Couratier

Tours, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 158 publications

Tofersen Treatment in SOD1-ALS: Real-World Evidence from a Retrospective Multicenter Study in France (FORSLA Study).

Tofersen Treatment in SOD1-ALS: Real-World Evidence from a Retrospective Multicenter Study in France (FORSLA Study).

Journal: Mayo Clinic proceedings. Innovations, quality & outcomes

Published: August 04, 2026

Primary Lateral Sclerosis French National Diagnostic and Care Protocol.

Primary Lateral Sclerosis French National Diagnostic and Care Protocol.

Journal: Revue neurologique

Published: April 01, 2026

Anchoring ALS Prognosis: Neurofilament Light Chain Outperforms Inflammatory, Metabolic, and CNS Barrier Biomarkers in the METABALS Cohort.

Anchoring ALS Prognosis: Neurofilament Light Chain Outperforms Inflammatory, Metabolic, and CNS Barrier Biomarkers in the METABALS Cohort.

Journal: Molecular neurobiology

Published: February 03, 2026

Evaluation of Digital Technologies for Home-Based Assessment in People With Amyotrophic Lateral Sclerosis.

Evaluation of Digital Technologies for Home-Based Assessment in People With Amyotrophic Lateral Sclerosis.

Journal: Annals of clinical and translational neurology

Published: December 23, 2025

The economic burden of amyotrophic lateral sclerosis for patients and families: a survey on out-of-pocket expenses and income loss in France.

The economic burden of amyotrophic lateral sclerosis for patients and families: a survey on out-of-pocket expenses and income loss in France.

Journal: Orphanet journal of rare diseases

Published: November 23, 2025

Bi-allelic intermediate ATXN2 repeat expansions are associated with slow progressing, leg-onset familial ALS.

Bi-allelic intermediate ATXN2 repeat expansions are associated with slow progressing, leg-onset familial ALS.

Journal: BMJ neurology open

Published: November 11, 2025

Treatment pathway, healthcare resource utilization and direct cost of ALS in France: A nationwide claims database study.

Treatment pathway, healthcare resource utilization and direct cost of ALS in France: A nationwide claims database study.

Journal: Revue neurologique

Published: October 27, 2025

Large-scale exome analyses reveal new rare variant contributions in amyotrophic lateral sclerosis.

Large-scale exome analyses reveal new rare variant contributions in amyotrophic lateral sclerosis.

Journal: Nature genetics

Published: August 15, 2025

Quantifying multimodal longitudinal brain changes in presymptomatic C9orf72 disease.

Quantifying multimodal longitudinal brain changes in presymptomatic C9orf72 disease.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: July 21, 2025

Improving ALS Molecular Diagnosis Through Functional Assays: Reassessment of a SOD1 Variant of Uncertain Significance.

Improving ALS Molecular Diagnosis Through Functional Assays: Reassessment of a SOD1 Variant of Uncertain Significance.

Journal: International journal of molecular sciences

Published: July 07, 2025

Hospitalizations as an outcome measure in COURAGE-ALS.

Hospitalizations as an outcome measure in COURAGE-ALS.

Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration

Published: June 12, 2025

Prevalence of SOD1 and C9orf72 Variants Among French ALS Population: The GENIALS Study.

Prevalence of SOD1 and C9orf72 Variants Among French ALS Population: The GENIALS Study.

Journal: European journal of neurology

Published: May 01, 2025

Showing 1-12 of 158

Last Updated: 09/26/2026